Skip to main content
main-content

Osteoarthritis

Highlights

21-12-2018 | Osteoarthritis | Highlight | News

Long-term impact unclear for knee OA medications

Findings from a systematic review and network meta-analysis published in JAMA indicate that it is not clear whether pharmacologic treatments offer long-term benefits for patients with knee osteoarthritis.

Source:

JAMA 2018; 320: 2564–2579

22-11-2018 | Osteoarthritis | Highlight | News

Interdisciplinary intervention improves hand grip strength in OA patients

A single-session nonpharmacologic intervention delivered by rheumatology-trained healthcare professionals from different disciplines improves grip strength among patients with hand osteoarthritis, randomized trial findings suggest.

Source:

Arthritis Res Ther 2018; 20: 253

06-09-2018 | Calcium crystal deposition disease | Review | Article

Calcium crystal deposition diseases: Beyond gout

McCarthy GM, Dunne A. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0078-5

07-09-2018 | Treatment | Feature | Article

At a glance: Common scores used in rheumatology

A quick-reference guide to the scores that are commonly used in clinical trials and daily rheumatology practice.

03-09-2018 | Osteoarthritis | Highlight | News

Weight gain may be linked to development of knee OA in overweight patients

Overweight and obese women who gain weight over a 2.5-year period are more likely to experience progression of knee joint synovitis than those who maintain a stable bodyweight, research suggests.

Source:

Osteoarthritis Cartilage 2018; doi:10.1016/j.joca.2018.08.006

30-08-2018 | Osteoarthritis | Highlight | News

Updated EULAR guidance for managing hand OA published

EULAR has issued updated recommendations for the management of hand osteoarthritis based on current evidence and expert opinion.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-213826

28-08-2018 | Osteoarthritis | Highlight | News

Oral OA therapy not linked to knee replacement risk

Exposure to oral osteoarthritis therapies is unlikely to be a risk factor for requiring knee replacement, suggests an analysis of the Osteoarthritis Initiative database.

Source:

Arthritis Res Ther 2018; 20: 172

11-07-2018 | Arthroplasty | Review | Article

Total joint arthroplasty in patients with inflammatory rheumatic diseases

Compagnoni R, Gualtierotti R, Randelli P. Adv Ther 2018. doi: 10.1007/s12325-018-0750-9

20-07-2018 | Physical activity | Highlight | News

Physical activity recommendations for patients with OA and inflammatory arthritis published

EULAR has issued evidence-based recommendations for physical activity in patients with osteoarthritis and inflammatory arthritis.

Source:

Ann Rheum Dis 2018; doi:10.1136/annrheumdis-2018-213585

12-06-2018 | Osteoarthritis | Article

Living with osteoarthritis is a balancing act: An exploration of patients’ beliefs about knee pain

This study aimed to explore the beliefs of people with knee osteoarthritis about the disease, and how these beliefs had formed and what impact these beliefs had on activity participation, health behaviour, and self-management.

Darlow B et al. BMC Rheumatol 2018; 2: 15. doi: 10.1186/s41927-018-0023-x

14-06-2018 | Osteoarthritis | EULAR 2018 | News

News in brief

Disease severity linked to depression risk in OA patients

More severe structural disease is associated with an increased risk for depression among patients with radiographic knee osteoarthritis, according to study results presented at the EULAR 2018 meeting in Amsterdam, the Netherlands.

08-05-2018 | Osteoarthritis | Article

Benefits and safety of dietary protein for bone health: An expert consensus paper endorsed by the European Society for Clinical and Economical Aspects of Osteopororosis, Osteoarthritis, and Musculoskeletal Diseases and by the International Osteoporosis Foundation

This summary of systematic reviews and meta-analyses addresses the benefits and risks of dietary protein intakes for bone health in adults.

Rizzoli R et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4534-5

02-05-2018 | Spondyloarthropathies | Highlight | News

Diclofenac linked to increased myocardial infarction risk in SpA patients

Current use of the nonsteroidal anti-inflammatory drug diclofenac, but not of naproxen, is associated with a threefold increased risk for myocardial infarction among individuals with spondyloarthritis, according to recent findings.

Source:

Ann Rheum Dis 2018; Advance online publication

06-03-2018 | Osteoarthritis | Highlight | News

Trial results do not support opioid therapy for back or OA pain

Results of the SPACE trial suggest that opioids do not offer superior pain relief to nonopioid medications for patients with chronic back pain or osteoarthritis.

Source:

JAMA 2018; 319: 872–882

25-01-2017 | Osteoarthritis | Review | Article

Osteoarthritis in 2016: Anti-NGF treatments for pain — two steps forward, one step back?

This review explores the role of nerve growth factor inhibitors as a treatment for the reduction of chronic musculoskeletal pain and the developments and limitations of this potential therapy.

Nat Rev Rheumatol 2017;13:76–78. doi:10.1038/nrrheum.2016.224

Authors:
Nancy E. Lane, Maripat Corr
image credits